KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 129 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21 | -25.0% | 15,431 | 0.0% | 0.00% | – |
| Q2 2023 | $28 | -31.7% | 15,431 | +46.0% | 0.00% | – |
| Q1 2023 | $41 | 0.0% | 10,571 | -12.0% | 0.00% | – |
| Q4 2022 | $41 | -99.9% | 12,012 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $66,000 | +24.5% | 12,012 | +1.6% | 0.00% | – |
| Q2 2022 | $53,000 | -38.4% | 11,818 | +0.8% | 0.00% | -100.0% |
| Q1 2022 | $86,000 | -47.6% | 11,722 | -53.9% | 0.00% | 0.0% |
| Q4 2021 | $164,000 | +115.8% | 25,424 | +94.7% | 0.00% | 0.0% |
| Q3 2021 | $76,000 | -45.7% | 13,061 | -3.9% | 0.00% | 0.0% |
| Q2 2021 | $140,000 | +32.1% | 13,596 | +35.0% | 0.00% | -75.0% |
| Q1 2021 | $106,000 | -37.6% | 10,074 | -8.1% | 0.00% | -33.3% |
| Q4 2020 | $170,000 | +6.9% | 10,962 | +0.6% | 0.01% | -14.3% |
| Q3 2020 | $159,000 | -25.4% | 10,901 | -2.9% | 0.01% | -30.0% |
| Q2 2020 | $213,000 | +4.9% | 11,228 | +6.2% | 0.01% | +100.0% |
| Q1 2020 | $203,000 | -2.4% | 10,574 | -2.8% | 0.01% | +25.0% |
| Q4 2019 | $208,000 | +110.1% | 10,874 | +6.0% | 0.00% | +100.0% |
| Q3 2019 | $99,000 | +59.7% | 10,258 | -0.7% | 0.00% | +100.0% |
| Q2 2019 | $62,000 | – | 10,335 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |